Dr. Kyle Alexander Deville, MD

Dr. Deville practices at Childrens Hospital of Alabama in Birmingham, Alabama.

Dr. Deville's NPI, 1033643556, was assigned on April 12, 2017. Dr. Deville graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2017. Dr. Deville's Alabama license number on file is MD.37426.

Dr. Deville's primary practice is Childrens Hospital of Alabama, at 1600 Z Ave, Birmingham, AL 35208 in Jefferson County. The practice phone is (205) 638-9100.

Dr. Deville's primary practice is Childrens Hospital of Alabama in Birmingham, Alabama. Dr. Deville is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Deville to 1 more hospital and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deville practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Deville's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Deville is board certified in pediatric nephrology by the American Board of Pediatrics. Dr. Deville has a license on file in Alabama.

CMS data shows 28 Medicare services from Dr. Deville across 1 procedure code in 2024, all of them office visits, for 30 Medicare patients. Medicare paid $1,840 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. Deville in 2024. The largest group is under 65, with 30 patients. 75% of them have chronic kidney disease, and 67% have high blood pressure. Their average risk score is 6.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deville's median patient age at 13, with 45% women.

In 2024, Dr. Deville wrote 114 Medicare Part D claims for 20 patients. 92% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $331 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Deville accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Deville, published from 2016 to 2023. 2023 was the busiest year, with 2. Dr. Deville's most frequent co-authors are David J. Askenazi, MD, Nathan P. Charlton, MD and Michael Edward Seifert, MD.

CMS Open Payments shows 10 general payments to Dr. Deville from 9 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Apellis Pharmaceuticals, Inc. paid the most, $126.

Dr. Deville graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2017. Dr. Deville is a member of AAP, AMA, American Society of Transplant and National Kidney Foundation.

Dr. Deville is in network with 9 carriers, including United Healthcare, Cigna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.